The story has been updated to include comments from company officials from its earnings conference call.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that its second quarter revenues improved 4 percent year over year, as the company exceeded the average analyst estimates on the top and bottom lines.

Companywide revenues for the three months ended June 29 reached $3.24 billion, up from $3.11 billion a year ago, beating the consensus Wall Street estimate of $3.22 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.